Curis (CRIS) reported a loss of $0.09 per share in its second quarter, in-line with the consensus forecast. The company reported revenue of $1.68 million, down 19.2% on a year-over-year basis. Revenue missed consensus forecast by $0.37 million.

Acceleron Pharma (XLRN) reported a loss of $0.59 per share in its second quarter, missing consensus forecast by 9 cents. The company�s revenue for the quarter was $3.2 million, missing consensus forecast by $0.57 million.

AVEO Pharmaceuticals (AVEO) reported a loss of $0.13 per share in its second quarter, beating consensus forecast by a penny. The company�s revenue for the quarter was $0.2 million, up 53.8% on a year-over-year basis. Revenue beat consensus forecast by $0.1 million.

Trevena (TRVN) reported a loss of $0.37 per share in its second quarter, missing consensus forecast by a penny. The company reported revenue of $1.88 million, beating consensus forecast by $0.07 million.

Pacira Pharmaceuticals (PCRX) reported second-quarter earnings of $0.19 per share, beating consensus forecast by 16 cents. The company�s revenue for the quarter was $69.64 million, beating consensus forecast by $2.26 million. Revenue rose 17.7% on a year-over-year basis.

Karyopharm Therapeutics (KPTI) reported a loss of $0.84 per share in its second quarter, missing consensus forecast by 8 cents. The company reported revenue of $0.06 million, down 60% on a year-over-year basis. Revenue beat consensus forecast by $0.02 million.